Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for prevention of postpartum depression after cesarean section
ChiCTR2000039069Phase 4Recruiting
- Sponsor
- The Third Xiangya Hospital Anesthesia Department
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in postpartum depression (PPD) (3 arms), sponsored by The Third Xiangya Hospital Anesthesia Department. Primary endpoint: Prevalence of postpartum depression. Started Oct 2020; status: recruiting.
02
Drugs
esketamine
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on ChiCTR2000039069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039069.